The present and the future of vaccines and other preventive measures in the era of EID

Rosario Menendez Villanueva (Valencia, Spain)

Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions

Number: 4

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rosario Menendez Villanueva (Valencia, Spain). The present and the future of vaccines and other preventive measures in the era of EID. Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Current and future preventive and treatment strategies in CLAD Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation Year: 2015
How to make interventions more successful in the future Source: International Congress 2015 – PG13 Monitoring physical activity Year: 2015
Future prospects for improved influenza vaccines Source: Annual Congress 2007 - Respiratory issues in primary care Year: 2007
Population screening initiatives and future strategies Source: International Congress 2014 – Ceremony for the ERS COPD research Award 2014 - Symposium: Finding patients with COPD: how, when and where Year: 2014
Other options of prevention - the current state and the future Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003
Pandemic influenza: using evidence on vaccines and antivirals for clinical decisions and policy making Source: Eur Respir J 2006; 27: 661-663 Year: 2006
CF clinical care and its delivery: current and future challenges Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission Year: 2019
Halotherapy and Covid-19: an oppinion for a possible future prevention approach Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors Year: 2021
Influenza surveillance and vaccination: new developments Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017
ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies Source: Virtual Congress 2020 – New developments in pandemic medicine Year: 2020
Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation Source: Eur Respir J 2014; 44: 1412-1417 Year: 2014
New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012
The effectiveness of the national program tuberculosis control in Ukraine and the future strategy Source: Eur Respir J 2006; 28: Suppl. 50, 130s Year: 2006
Therapeutic management - Current status and future developments Source: COVID-19 Videos Year: 2020
Challenges, impact and the future Source: Eur Respir Monogr 2019; 83: 240-244 Year: 2019